Classified in: Health, Science and technology, Business
Subject: VEN

Healthcare Technology Company Lyfegen Successfully Raises CHF 750'000 in Seed Capital

BASEL, Switzerland, April 17, 2019 /PRNewswire/ -- Lyfegen HealthTech AG successfully closes its seed financing round, raising a total of CHF 750'000. The funding was led by Swiss private investors. The funds will be used to further build Lyfegen's value-based payments platform Lyfevalue and conduct further pilots with partners in the US, Africa, and the EU, including the UK.

Lyfegen HealthTech AG Logo (PRNewsfoto/Lyfegen HealthTech AG)

Lyfegen is a healthcare technology company that has developed a ground-breaking solution to accelerate value-based healthcare, entering a market set to grow to USD 390.7 billion by 2024 according to latest market research. Its platform, Lyfevalue, collects, analyses & reconciles disparate healthcare data for the purpose of automating value-based healthcare contracting. The platform enables life sciences companies, national and private healthcare payers and healthcare providers to operationalise value-based healthcare strategies whilst benefiting from a single holistic solution for their value-based healthcare operations. In addition, the platform allows for personalised healthcare by enabling patient level pricing, fostering accelerated and facilitated access to innovative treatments for patients.

"Enabling the shift to sustainable healthcare is a huge challenge, giving us at Lyfegen great purpose and we are honoured to work with individuals that truly care about making a difference for patients around the world," said Girisha Fernando, Lyfegen's CEO & Founder.

About Lyfegen

Lyfegen HealthTech AG was founded in October 2018 by Girisha Fernando, Michel Mohler, Nico Mros, Leon Rebolledo and James Gannon. After successful careers at F.Hoffmann-La Roche, Novartis AG and UBS AG, the founders have developed an innovative software solution to overcome technical hurdles in value-based healthcare. Its platform Lyfevalue enables life sciences, healthcare payers and providers to agree on and automatically execute value-based pricing contracts in a trusted, secure & compliant way.

These press releases may also interest you

at 14:29	iHealth Unveils Breakthrough 3-in-1 At-Home 15-Minute Antigen Test for COVID-19 and Flu A&B
	iHealth Labs, Inc. (iHealth®), a leading provider of digital health solutions, today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the company's 3-in-1 COVID-19/Flu A&B Rapid Test Kit...
at 14:24	Bulletproof Recognized as a Microsoft Security Excellence Awards Winner for Security Trailblazer
	Bulletproof today announced it won the Security Trailblazer award in the Microsoft Security Excellence Awards 2024. The company's innovation and achievements over the past 12 months have elevated and distinguished it within the Microsoft Intelligent...
at 14:20	Abel Communications Launches New On-Demand Thought Leadership Program
	Abel Communications, an award-winning public relations firm, has announced the launch of "Expertise, Amplified," an on-demand Thought Leadership program designed to programmatically and strategically raise the profile of subject matter experts....
at 14:15	Genesis Unveils Emerging Technology, HOCl Atomizing, for 'Air Quality Awareness Week'
	Frederick, MD-based Genesis + HOCL introduces two HOCl atomizing machines for Air Quality Awareness Week. Genesis is the sole U.S. distributor of this technology, previously only available in Japan and South Korea, bringing the Genesis 2.6 and UX4 to...
at 14:09	Federal government partners with Indigenous Peoples in Timiskaming District
	The federal government is investing in green and inclusive retrofits for Indigenous education facilities in Kirkland Lake and Temiskaming Shores to convert land in Kirkland Lake into a food forest. Announced by MP Anthony Rota and Bertha Cormier,...
at 14:05	Avicenna Introduces Machine Learning-Enhanced Medicinal Chemistry Platform to Accelerate the Last Mile of Small Molecule Drug Discovery
	Avicenna Biosciences today introduced an extension to its machine learning (ML) technology platform to enhance medicinal chemistry and expedite clinical-stage drug discovery. The company has raised $14.5 million in funding to date, with DCVC Bio...
	More news about Science and technology...

News published on 17 april 2019 at 05:00 and distributed by:

Healthcare Technology Company Lyfegen Successfully Raises CHF 750'000 in Seed Capital

These press releases may also interest you

Le Lézard

Others sections

Follow us